WHO Listing Signals Stronger Global Trust in Medical Product Regulation Systems
A major milestone in global health governance has been reached as regulatory authorities from both developed and emerging economies gain top-tier international recognition, reinforcing confidence in the safety and quality of medical products worldwide.
Strengthening Global Regulatory Confidence
The World Health Organization has formally recognized Australia’s Therapeutic Goods Administration and Indonesia’s Food and Drug Authority as WHO Listed Authorities, marking a significant expansion of global regulatory excellence. This recognition confirms that both agencies meet WHO’s highest international standards for overseeing medical products, including medicines and vaccines.
With these additions, the global WLA network now includes 41 regulatory authorities from 39 countries. The growing list reflects WHO’s push toward a more inclusive and geographically diverse regulatory ecosystem that supports equitable access to safe and effective health products.
A More Connected Regulatory Ecosystem
Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data, emphasized that expanding the WLA network strengthens international cooperation. According to WHO, reliance on WLA decisions helps reduce duplication of regulatory work, ease supply chain bottlenecks, and accelerate access to essential medicines and vaccines, particularly during health emergencies.
The framework also plays a critical role in supporting the WHO Prequalification Programme, enabling governments and procurement bodies worldwide to rely on trusted regulatory assessments.
Rigorous and Science-Based Assessment
WLA status is granted only after a voluntary, comprehensive evaluation based on internationally agreed scientific and technical standards. Regulatory authorities must demonstrate advanced and reliable oversight across specific areas of medical product regulation, ensuring transparency, consistency, and long-term system resilience.
This process reflects WHO’s broader goal of building trustworthy regulatory systems that protect public health while supporting global supply stability.
Indonesia Sets a Landmark Precedent
Indonesia’s Food and Drug Authority made history by becoming the first standalone regulatory authority from a middle-income country to achieve WLA status. The designation reflects sustained political commitment, long-term investment, and strong vaccine regulatory oversight within one of the world’s largest and most complex health markets.
The achievement signals that advanced regulatory capacity is attainable beyond high-income economies and is expected to encourage other low- and middle-income countries to pursue similar pathways.
Completing the Global Transition
Australia’s TGA recognition completes the transition of all former “stringent regulatory authorities” into the unified WLA framework. This shift creates a single, transparent, and predictable global system that governments, WHO programs, and international procurers can rely on with confidence.
TGA’s long-standing role as a reference authority continues, now reinforced by modern regulatory approaches that emphasize convergence, reliance, and mutual trust.
Growing Momentum Worldwide
WHO confirmed that several other national regulatory authorities have already expressed interest in entering the WLA assessment process. This growing momentum highlights increasing global confidence in the framework and its role in strengthening health security worldwide.
The recognition of Australia and Indonesia as WHO Listed Authorities marks a critical step toward a more resilient, inclusive, and trusted global health regulatory system. For Indonesians and Singaporeans alike, stronger regional and international regulatory cooperation enhances access to quality-assured medicines and vaccines, reinforcing public health protection and cross-border health security.
Sources: WHO (2026)
Keywords: WHO Listed Authorities, Medical Product Regulation, Vaccine Oversight, Global Health Security
